Polycystic kidney disease: Identifying a pathogenic pathway

The occurrence of septic shock: difficulty in predicting the outcomes

Mass spectrometry: a key metabolomics platform in metabolic diseases

Pharmametabolomics and the integration of metabolomics in drug discovery

How can metabolomics help in clinical diagnosis?

Revisiting intrathecal therapy for childhood medulloblastoma

Convection enhanced delivery of chemotherapy to paediatric brain stem tumours

Intra-arterial chemotherapy methods for CNS tumours

Using nanoparticles to target paediatric brain tumours

Treating relapsed brain tumours with anti-angiogenic metronomic therapy

Intrathecal cytarabine for paediatric brain tumours

Delivering drugs to CNS tumours: techniques and challenges